Sort
40,608 grants matching “prostate cancer”
PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)
$1,114,478Thomas Riley · Information Management Services, Inc. · N02 · FY2022 · CA
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$1,114,476Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
$1,114,283Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2021 · CA
Environmental factors and compounds affecting the genomic stability in haploinsufficient BRCA1 cells.
$1,114,041Jeannine Gerhardt · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · ES
CONNEXINS AND CADHERIN CROSSTALK IN THE PATHOGENESIS OF PROSTATE CANCER
$1,113,750Board Of Regents Of The University Of Nebraska · · FY2012 · Department of Defense
Regulation of epithelial cell fate decisions in tissue homeostasis and cancer
$1,113,209Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
CENTER FOR BIOMEDICAL RESEARCH
$1,112,067Timothy Turner · Tuskegee University · G12 · FY2013 · MD
Genetic Epidemiology of Cancer
$1,110,655Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2021 · HG
DEVELOPMENT OF IMMUCHIP, AN EARLY DIAGNOSTIC TEST FOR OVARIAN AND PROSTATE CANCER
$1,110,000Immunotope Inc · · FY2010 · Department of the Army
IMAGING AND TARGETED SYSTEMIC THERAPY OF PROSTATE CANCER WITH ANTIBODY TO ANNEXIN A1
$1,110,000Proteogenomics Research Institute For Systems Medicine · · FY2018 · Department of the Army
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,810Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2021 · CA
Genetic Epidemiology of Lung Cancer
$1,109,255Marshall W Anderson · University Of Cincinnati · U01 · FY2007 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,082Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2022 · CA
Center of Excellence for Cancer Research, Training and Community Service
$1,109,043Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2015 · MD
The HARVARD UROLOGIC RESEARCH CENTER
$1,108,206Michael R Freeman · Boston Children'S Hospital · P50 · FY2006 · DK
Clinical Trials with Immunotoxins
$1,108,096Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein*
$1,108,052Shaomeng Wang · University Of Michigan At Ann Arbor · U19 · FY2009 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Center for Applied Preclinical Research (CAPR)
$1,107,608Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Mouse Models of Prostate Cancer
$1,107,477Norman Michael Greenberg · Fred Hutchinson Cancer Research Center · U01 · FY2007 · CA
Germline modifiers of tumor progression and metastasis in prostate cancer
$1,107,427Nigel Crawford · National Human Genome Research Institute · ZIA · FY2016 · HG
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$1,107,013John David Carpten · University Of Southern California · U54 · FY2019 · CA
An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.
$1,106,781William Valentine Williams · Briacell Therapeutics Corp · R44 · FY2025 · CA
CREATION AND VALIDATION OF A PREBIOPSY NOMOGRAM FOR PREDICTING HIGH-RISK PROSTATE CANCER IN AFRICAN AMERICAN MEN
$1,106,569Northwestern University · · FY2017 · Department of the Army